1. Practical Considerations to Extend Treatment for VTE

3. VTE Acute, Long-Term, and Extended Treatment

4. Provoked VTE

5. Unprovoked VTE

6. Men Are at Higher Risk of VTE Than Are Women

7. HERDOO2 Rule

8. VTE Extension Trials: NOACs vs Placebo

9. Extending Anticoagulation

10. Bleeding

11. ASPIRIN: WARFASA and INSPIRE

12. EINSTEIN Choice Study Design

13. EINSTEIN Choice Primary Outcome -- Recurrent VTE

14. EINSTEIN Choice Bleeding Outcomes

15. EINSTEIN Choice: Provoked, Unprovoked, and History of VTE

16. AMPLIFY-EXT Efficacy and Safety

17. NOACs in Prevention of Cancer-Associated VTE

18. Adherence

19. Timing of Doses

20. Anticoagulation and Need for Antiplatelet Therapy

21. Summary

22. Abbreviations